Deterministic, compensatory mutational events in the capsid of foot-and-mouth disease virus in response to the introduction of mutations found in viruses from persistent infections

Journal of Virology

Volumn 81, Issue 4, 2007, Pages 1879-1887

  Mateo, Roberto ^a   Mateu, Mauricio G ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FOOT AND MOUTH DISEASE VIRUS; GENE CLUSTER; GENETIC CONSERVATION; GENOTYPE PHENOTYPE CORRELATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CAPSID; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MUTATION; PLAQUE ASSAY;

FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 33846784067     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01899-06     Document Type: Article

References (60)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716.
2. Airaksinen, A., M. Roivainen, and T. Hovi. 2001. Coxsackievirus A9 VP mutants with enhanced or hindered A particle formation and decreased infectivity. J. Virol. 75:952-960.
3. Almond, B. D., and D. H. Dean. 1993. Suppression of protein structure destabilizing mutations in Bacillus thuringiensis delta-endotoxins by second site mutations. Biochemistry 32:1040-1046.
4. Baranowski, E., N. Sevilla, N. Verdaguer, C. M. Ruiz-Jarabo, E. Beck, and E. Domingo. 1998. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 72:6362-6372.
5. Blacklow, S. C., and J. R. Knowles. 1990. How can a catalytic lesion be offset? The energetics of two pseudorevertant triosephosphate isomerases. Biochemistry 29:4099-4108.
6. Bouvier, S. E., and A. R. Poteete. 1996. Second-site reversion of a structural defect in bacteriophage T4 lysozyme. FASEB J. 10:159-163.
7. Brown, K. A., E. E. Howell, and J. Kraut. 1993. Long-range structural effects in a second-site revenant of a mutant dihydrofolate reductase. Proc. Natl. Acad. Sci. USA 90:11753-11756.
8. Bubeck, D., D. J. Filman, N. Cheng, A. C. Steven, J. M. Hogle, and D. M. Belnap. 2005. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J. Virol. 79:7745-7755.
9. Carreira, A., and M. G. Mateu. 2006. Structural tolerance versus functional intolerance to mutation of hydrophobic core residues surrounding cavities in a parvovirus capsid. J. Mol. Biol. 360:1081-1093.
10. Chanel-Vos, C., and M. Kielian. 2006. Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein. J. Virol. 80:6115-6122.
11. Cimarelli, A., S. Sandin, S. Hoglund, and J. Luban. 2000. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. J. Virol. 74:4273-4283.
12. Das, G., D. R. Hickey, D. McLendon, G. McLendon, and F. Sherman. 1989. Dramatic thermostabilization of yeast iso-1-cytochrome c by an asparagine-isoleucine replacement at position 57. Proc. Natl. Acad. Sci. USA 86:496-499.
13. de la Torre, J. C., M. Dávila, F. Sobrino, J. Ortín, and E. Domingo. 1985. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 145:24-35.
14. de la Torre, J. C., E. Martínez-Salas, J. Díez, A. Villaverde, F. Gebauer, E. Rocha, M. Dávila, and E. Domingo. 1988. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J. Virol. 62:2050-2058.
15. Deom, C. M., and X. Z. He. 1997. Second-site reversion of a dysfunctional mutation in a conserved region of the tobacco mosaic tobamovirus movement protein. Virology 232:13-18.
16. Díez, J., M. Dávila, C. Escarmís, M. G. Mateu, J. Domínguez, J. J. Pérez, E. Giralt, J. A. Melero, and E. Domingo. 1990. Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J. Virol. 64:5519-5528.
17. Domingo, E., (ed.). 2006. Current topics in microbiology and immunology, vol. 299. Quasispecies. Concepts and implications for virology. Springer, New York, NY. Curr. Top. Microbiol. Immunol. 299:51-82.
18. Domingo, E., and J. J. Holland. 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:151-178.
19. Domingo, E., C. Escarmís, L. Menéndez-Arias, and J. J. Holland. 1999. Viral quasispecies and fitness variations, p. 141-161. In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, San Diego, CA.
20. Domingo, E., C. Biebricher, M. Eigen, and J. J. Holland. 2001. Quasispecies and RNA virus evolution: principles and consequences. Landes Bioscience, Austin, TX.
21. Ebert, C. E., and D. S. Beattie. 2004. A compensatory double mutation of the alanine-86 to leucine mutant located in the hinge region of the iron-sulfur protein of the yeast cytochrome bel complex. Arch. Biochem. Biophys. 429:16-22.
22. Escarmís, C., E. C. Carrillo, M. Ferrer, J. F. García-Arriaza, N. López, C. Tami, N. Verdaguer, E. Domingo, and M. T. Franze-Fernández. 1998. Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism. J. Virol. 72:10171-10179.
23. Fares, M. A., and S. A. A. Travers. 2006. A novel method for detecting intramolecular coevolution: adding a further dimension to selective constraints analysis. Genetics 173:9-21.
24. Filman, D. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-1579.
25. Hartzog, P. E., and B. D. Cain. 1994. Second-site suppressor mutations at glycine 218 and histidine 245 in the alpha subunit of F1F0 ATP synthase in Escherichia coli. J. Biol. Chem. 269:32313-32317.
26. Jarvik, J., and D. Botstein. 1975. Conditional-lethal mutations that suppress genetic defects in morphogenesis by altering structural proteins. Proc. Natl. Acad. Sci. USA 72:2738-2742.
27. Joerger, A. C., M. D. Allen, and A. R. Fersht. 2004. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J. Biol. Chem. 279:1291-1296.
28. Kim, H.-W., T. J. Shen, D. P. Sun, N. T. Ho, M. Madrid, M. F. Tam, M. Zou, P. F. Cottam, and C. Ho. 1994. Restoring allosterism with compensatory mutations in hemoglobin. Proc. Natl. Acad. Sci. USA 91:11547-11551.
29. Klig, L. S., D. L. Oxender, and C. Yanofsky. 1988. Second-site revertants of Escherichia coli trp represser mutants. Genetics 120:651-655.
30. Kondrashov, A. S., S. Sunyaev, and F. A. Kondrashov. 2002. Dobzhansky-Muller incompatibilities in protein evolution. Proc. Natl. Acad. Sci. USA 99:14878-14883.
31. Kulathinal, R. J., B. R. Bettencourt, and D. L. Hartl. 2004. Compensated deleterious mutations in insect genomes. Science 306:1553-1554.
32. Lea, S., J. Hernández, W. Blakemore, E. Brocchi, S. Curry, E. Domingo, E. Fry, R. Abu-Ghazaleh, A. King, J. Newman, D. Stuart, and M. G. Mateu. 1994. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2:123-139.
33. Machingo, Q., M. Mazourek, and W. Cameron. 2001. Second-site, intragenic alterations in the gene encoding subunit II of cytochrome c oxidase from yeast can suppress two different missense mutations. Curr. Genet. 39:297-304.
34. Martín-Hernández, A. M., E. C. Carrillo, N. Sevilla, and E. Domingo. 1994. Rapid cell variation can determine the establishment of a persistent viral infection. Proc. Natl. Acad. Sci. USA 91:3705-3709.
35. Mateo, R., A. Díaz, E. Baranowski, and M. G. Mateu. 2003. Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function. J. Biol. Chem. 278:41019-41027.
36. Mateu, M. G., and A. R. Fersht. 1999. Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization. Proc. Natl. Acad. Sci. USA 96:3595-3599.
37. Nikolova, P. V., K. B. Wong, B. DeDecker, J. Henckel, and A. R. Fersht. 2000. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations. EMBO J. 19:370-378.
38. Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher. 1999. Increased fitness of drug-resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13:2349-2359.
39. Olivares, I., V. Sánchez-Merino, M. A. Martínez, E. Domingo, C. López-Galíndez, and L. Menéndez-Arias. 1999. Second-site reversion of a human immunodeficiency virus type 1 reverse transcriptase mutant that restores enzyme function and replication capacity. J. Virol. 73:6293-6298.
40. Olivares, I., M. Gutiérrez-Rivas, C. López- Galíndez, and L. Menéndez-Arias. 2004. Tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of HIV-1 reverse transcriptase: critical role of Phe-130 for p51 function and second-site revertant restoring viral replication capacity. Virology 324:400-411.
41. Ono, A., M. Huang, and E. O. Freed. 1997. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71:4409-4418.
42. Pazhanisamy, S., C. M. Stuver, A. B. Cullinan, N. Margolin, B. G. Rao, and D. J. Livingston. 1996. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants. J. Biol. Chem. 271:17979-17985.
43. Pelemans, H., R. Esnouf, K. L. Min, M. Parniak, E. De Clercq, and J. Balzarini. 2001. Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a Trp229Tyr mutant RT. Virology 287:143-150.
44. Poon, A., and L. Chao. 2005. The rate of compensatory mutation in the DNA bacteriophage ΦX174. Genetics 170:989-999.
45. Poteete, A. R., D. Rennell, S. E. Bouvier, and L. W. Hardy. 1997. Alteration of T4 lysozyme structure by second-site reversion of deleterious mutations. Protein Sci. 6:2418-2425.
46. Regan, L., L. Buxbaum, K. Hill, and P. Schimmel. 1988. Rationale for engineering an enzyme by introducing a mutation that compensates for a deletion. J. Biol. Chem. 263:18598-18600.
47. Reguera, J., A. Carreira, L. Riolobos, J. M. Almendral, and M. G. Mateu. 2004. Role of interfacial amino acid residues in assembly, stability and conformation of a spherical virus capsid. Proc. Natl. Acad. Sci. USA 101:2724-2729.
48. Sapunaric, F. M., and S. B. Levy. 2003. Second-site suppressor mutations for the serine 202 to phenylalanine substitution within the interdomain loop of the tetracycline efflux protein Tet(C). J. Biol. Chem. 278:28588-28592.
49. Sevilla, N., and E. Domingo. 1996. Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification. J. Virol. 70:6617-6624.
50. Shiomi, H., T. Urasawa, S. Urasawa, N. Kobayashi, S. Abe, and K. Taniguchi. 2004. Isolation and characterization of poliovirus mutants resistant to heating at 50°C for 30 min. J. Med. Virol. 74:484-491.
51. Sobrino, F., M. Dávila, J. Ortín, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus. Virology 128:310-318.
52. Tachedjian, G., H. E. Aronson, and S. P. Goff. 2000. Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 97:6334-6339.
53. Thompson, J. R., S. Doun, and K. L. Perry. 2006. Compensatory capsid protein mutations in cucumber mosaic virus confer systematic infectivity in squash (Cucurbita pepo). J. Virol. 80:7740-7743.
54. Toja, M., C. Escarmís, and E. Domingo. 1999. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64:161-171.
55. Twomey, T., L. L. France, S. Hassard, T. G. Burrage, J. F. E. Newman, and F. Brown. 1995. Characterization of an acid-resistant mutant of foot-and-mouth disease virus. Virology 206:69-75.
56. Wray, J. W., W. A. Baase, J. D. Lindstrom, L. H. Weaver, A. R. Poteete, and B. W. Matthews. 1999. Structural analysis of a non-contiguous second-site revertant in T4 lysozyme show that increasing the rigidity of a protein can enhance its stability. J. Mol. Biol. 292:1111-1120.
57. Wu, T. D., C. A. Schiffer, M. J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A. R. Zolopa, W. F. Fessel, and R. W. Shafer. 2003. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 77:4836-4847.
58. + antiporter of Escherichia coli. J. Biol. Chem. 268:26990-26995.
59. Yuan, T. T., and C. Shih. 2000. A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L). J. Virol. 74:4929-4932.
60. Zibert, A., G. Maass, K. Strebel, M. M. Falk, and E. Beck. 1990. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 64:2467-2473.